Movatec (Meloxicam)

Meloxicam, the active ingredient in Movatec, is a nonsteroidal anti-inflammatory drug (NSAID) presented as a tablet for oral use. It reduces inflammation and pain in conditions such as osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and acute musculoskeletal pain.

GNH USA supplies Movatec as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Meloxicam is an NSAID that targets inflammatory joint and musculoskeletal disorders.

Osteoarthritis: alleviates joint pain and improves function in degenerative joint disease. Rheumatoid arthritis: decreases inflammation and pain, helping to preserve joint integrity. Ankylosing spondylitis: reduces spinal inflammation and stiffness, improving mobility. Acute musculoskeletal pain: provides rapid relief of pain and swelling following injury or overuse.

Meloxicam may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Gastrointestinal discomfort, such as dyspepsia or nausea. - Headache or dizziness. - Mild skin rash or itching. - Elevated liver enzymes detected in laboratory tests.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding, which can be life‑threatening. - Cardiovascular events including myocardial infarction or stroke. - Severe skin reactions such as Stevens‑Johnson syndrome or toxic epidermal necrolysis.

Before prescribing meloxicam, clinicians should consider several safety aspects.

Renal function: assess kidney function and avoid use in severe renal impairment. Cardiovascular risk: use cautiously in patients with a history of heart disease or hypertension. Gastrointestinal history: avoid in individuals with active ulcers or prior GI bleeding. Concomitant anticoagulants: monitor bleeding risk when combined with warfarin or similar agents. Pregnancy and lactation: evaluate risk‑benefit, as safety data are limited. Store at ambient temperature: keep below 25°C in the original packaging, protected from moisture.

Meloxicam can interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of serious bleeding. - Other NSAIDs or aspirin: heightened gastrointestinal toxicity. - Lithium: elevated lithium levels leading to toxicity. - Methotrexate: reduced clearance and potential toxicity. - High‑dose corticosteroids: additive risk of ulceration.

Moderate Interactions (Monitor Closely): - Diuretics (especially thiazides): possible reduction in renal function. - ACE inhibitors or ARBs: may diminish antihypertensive effect and affect kidney function. - Selective serotonin reuptake inhibitors (SSRIs): modest increase in bleeding risk.